Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 5, pp. 1157-1164
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 4, 2019
- Revision received December 7, 2019
- Accepted February 13, 2020
- Published first March 3, 2020.
Article Versions
- Previous version (March 3, 2020 - 06:59).
- Previous version (April 21, 2020 - 07:50).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Vincenza Conteduca1,2,
- Sheng-Yu Ku1,
- Loredana Puca3,
- Megan Slade4,
- Luisa Fernandez4,
- Judy Hess3,
- Rohan Bareja3,
- Panagiotis J. Vlachostergios3,
- Michael Sigouros3,
- Juan Miguel Mosquera3,
- Andrea Sboner3,
- David M. Nanus3,
- Olivier Elemento3,
- Ryan Dittamore4,
- Scott T. Tagawa3, and
- Himisha Beltran1,3,*
- 1Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
- 2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
- 3Weill Cornell Medicine, New York, New York.
- 4Epic Sciences, Inc., San Diego, California.
- ↵*Corresponding Author:
Himisha Beltran, Dana Farber Cancer Institute, 450 Brookline Avenue, Sm 758, Boston, MA 02215. Phone: 617-582-9421; Fax: 617-632-2165; E-mail: himisha_beltran{at}dfci.harvard.edu
May 2020
Volume 19, Issue 5
Volume 19, Issue 5
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
Jump to section
Advertisement